Picture of Regencell Bioscience Holdings logo

RGC Regencell Bioscience Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Brief: Regencell Bioscience’s Standardized Formulae Shown To Reduce ADHD, ASD Symptoms

Sept 12 (Reuters) - Regencell Bioscience Holdings Ltd
 RGC.O :
    * REGENCELL BIOSCIENCE’S STANDARDIZED FORMULAE ARE SHOWN TO
REDUCE
ADHD AND ASD SYMPTOMS IN THE INTERIM RESULTS OF ITS SECOND
EFFICACY TRIAL

Source text for Eikon:  ID:nBwCgG17a 
Further company coverage:  RGC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Regencell Bioscience Holdings

See all news